Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-04-13 Report Publication Anno…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Notice of Results
Report Publication Announcement Classification · 98% confidence The document is a short announcement (RNS Number: 0403W) dated April 13, 2023, titled "Notice of Results." It explicitly states that the company "plans to publish its annual report and financial results on Friday, April 28, 2023." It also mentions that a presentation and conference call will discuss these results. Because the document is an announcement about the future publication of reports (Annual Report and related discussions) rather than the reports themselves, and it is distributed via RNS, it fits the definition of a Report Publication Announcement (RPA). The document length is relatively short (5082 chars), supporting the 'announcement vs. report' distinction (Rule 2).
2023-04-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing code for this activity is POS.
2023-04-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement (RNS Number : 8839V) from PureTech Health PLC, dated April 12, 2023. The title explicitly states 'Transaction in Own Shares'. The content details the purchase of ordinary shares as part of a Share Buyback Programme, providing specific transaction dates, volumes, and prices. This directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2023-04-12 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement from PureTech Health PLC dated April 11, 2023. The title explicitly states 'Transaction in Own Shares' and the content details the purchase of ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of a company reporting the purchase or sale of its own shares. Reviewing the filing types: - 10-K, AR, IR, ER, MRQ are financial reports, which this is not. - DIRS relates to director's personal trades, not company buybacks. - The most fitting category is 'Transaction in Own Shares' (Code: POS), which covers share repurchase/issuance by the company itself.
2023-04-11 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is titled 'Transaction in Own Shares' and explicitly details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction details (Date, Number of shares purchased, Highest/Lowest/VWAP price) and updates the total number of shares in treasury and in issue. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares. Therefore, the correct classification is Transaction in Own Shares (POS).
2023-04-06 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'PureTech Health PLC' announces 'Transaction in Own Shares' as part of its 'Share Buyback Programme'. It details the date of purchase, number of shares purchased, and the resulting treasury share balance. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS), which covers the company buying back or selling its own shares.
2023-04-05 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.